Lion Point Capital, LP - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lion Point Capital, LP ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$22,718,000
+60.2%
1,204,6000.0%2.53%
+81.4%
Q2 2019$14,178,000
-18.3%
1,204,600
-5.3%
1.40%
-11.0%
Q1 2019$17,355,000
+190.9%
1,271,500
+118.5%
1.57%
+67.2%
Q4 2018$5,965,000
-38.4%
582,0300.0%0.94%
+3.1%
Q3 2018$9,690,000
+5.4%
582,0300.0%0.91%
+9.9%
Q2 2018$9,196,000582,0300.83%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders